News

Neobiomics AB and Gennisium Pharma announce an exclusive collaboration for distribution of ProPrems® in France

Stockholm October 12, 2021 – Neobiomics and Gennisium Pharma have entered into a Distribution Agreement under which Gennisium has the exclusive rights to register, market and sell Neobiomics’ proprietary product ProPrems® in France, in effect immediately. ProPrems® is a high-quality product for safe food supplementation… Read More »Neobiomics AB and Gennisium Pharma announce an exclusive collaboration for distribution of ProPrems® in France

Neobiomics AB and ExCEEd Orphan s.r.o. announce exclusive cooperation for Central and Eastern Europe

Stockholm, Sweden, 21 May, 2021 – Neobiomics AB and ExCEEd Orphan s.r.o. have entered an exclusive distribution agreement valid for 14 countries in Central and Eastern Europe (CEE). The agreement includes marketing and sales of Neobiomics’ proprietary product ProPrems® and is in effect immediately.  Neobiomics is a Sweden-based company specialized in the area of neonatal and… Read More »Neobiomics AB and ExCEEd Orphan s.r.o. announce exclusive cooperation for Central and Eastern Europe

Neobiomics AB and Ewopharma AG announce an exclusive collaboration for distribution of ProPrems® in Switzerland

Stockholm, Sweden, 17 May, 2021 – Neobiomics AB and Ewopharma AG have entered an exclusive distribution agreement valid for the territory of Switzerland. The agreement includes marketing and sales of Neobiomics’ proprietary product ProPrems® and is in effect immediately. Neobiomics AB is a Sweden-based company… Read More »Neobiomics AB and Ewopharma AG announce an exclusive collaboration for distribution of ProPrems® in Switzerland